A first-in-human phase 1 dose escalation study of spartalizumab (PDR001), an anti-PD-1 antibody, in patients with advanced solid tumors
Journal
Journal for ImmunoTherapy of Cancer
Journal Volume
8
Journal Issue
1
Pages
e000530
Date Issued
2020
Author(s)
Naing A.
Gainor J.F.
Gelderblom H.
Forde P.M.
Butler M.O.
Sharma S.
Ochoa De Olza M.
Varga A.
Taylor M.
Schellens J.H.M.
Wu H.
Sun H.
Silva A.P.
Faris J.
Mataraza J.
Cameron S.
Bauer T.M.
SDGs
Publisher
BMJ Publishing Group
Type
journal article